Reimagining the future of healthcare
ASHLEY / Huntington’s Disease Community Advocate
Press Releases
Subscribe to receive breaking news alerts about uniQure.
Subscribe-
-
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
-
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635©(4)